Luminance has been acquired by Resilience Capital Partners
ShoreView Industries has sold Luminance to Resilience Capital Partners. Financial details have not been disclosed.
Founded in 1952, Luminance is one of the largest, fastest growing designers and distributors of lighting products serving the North America lighting market. The company offers stock lighting products to the residential and commercial markets and customized lighting solutions to the hospitality market.
Founded in 2001 by co-CEOs Steve Rosen and Bassem Mansour, Resilience Capital Partners is a middle-market private equity firm based in Cleveland, Ohio.
ShoreView invests in established companies with operations in North America, across a wide range of industries. The firm structures a variety of acquisition, recapitalization and build-up transactions, typically in businesses with revenues ranging between US$20–300 million.
Oaklins' team in Los Angeles advised the seller in this transaction.
Talk to the deal team
Eduard Bagdasarian
Oaklins Intrepid
Related deals
Hemink Groep has been acquired by Gimv
Gimv has acquired a majority stake in Hemink, a Dutch specialist in real estate renovation and maintenance. This transaction marks a new chapter for Hemink, as it seeks to expand its position as a national leader in sustainable property services through its new partnership with Gimv.
Learn moreOGD has been sold to Building Beyond Technology Group
Building Beyond Technology Group (BBTG) strengthens its position in the IT sector by welcoming OGD IT-Dienstverlening (OGD) to its platform. With over 1,400 employees, OGD is an established name in the Dutch market as a mission-critical IT service provider for large-scale clients. This addition not only increases BBTG’s scale but also enhances its domain expertise and execution capabilities through close cooperation with the other platform companies.
Learn moreThe Providence Projects has been acquired by UKAT Group
Celebrity-success rehabilitation center, The Providence Projects, has joined The UK Addiction Treatment (UKAT) Group, backed by Sullivan Street Equity Partners.
Learn more